Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness

Carlton K.K. Lee; Donald J. Glenn

doi:10.1016/0732-8893(95)00081-K

Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness

Carlton K.K. Lee, Donald J. Glenn

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18, 618.

Original language	English (US)
Pages (from-to)	231-233
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	22
Issue number	1-2
DOIs	https://doi.org/10.1016/0732-8893(95)00081-K
State	Published - 1995

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/0732-8893(95)00081-K

Cite this

@article{e8f4d42789fb4cd2889b9069622aa74b,

title = "Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness",

abstract = "In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18, 618.",

author = "Lee, {Carlton K.K.} and Glenn, {Donald J.}",

year = "1995",

doi = "10.1016/0732-8893(95)00081-K",

language = "English (US)",

volume = "22",

pages = "231--233",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness

AU - Lee, Carlton K.K.

AU - Glenn, Donald J.

PY - 1995

Y1 - 1995

N2 - In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18, 618.

AB - In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18, 618.

UR - http://www.scopus.com/inward/record.url?scp=0029084709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029084709&partnerID=8YFLogxK

U2 - 10.1016/0732-8893(95)00081-K

DO - 10.1016/0732-8893(95)00081-K

M3 - Article

C2 - 7587045

AN - SCOPUS:0029084709

VL - 22

SP - 231

EP - 233

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1-2

ER -

Cefotaxime and ceftriaxone use evaluation in pediatrics. Consideration of cost effectiveness

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this